Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

Dublin, March 12, 2026 (GLOBE NEWSWIRE)-- The "Next Generation RNA Therapeutics Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Modality, Type of Molecule, ...

(MENAFN- GlobeNewsWire - Nasdaq) The global RNA therapeutics and vaccines market size was valued at USD 0.21 billion in 2024 and is predicted to hit around USD 107.7 billion by 2034, rising at a 87% ...

San Francisco, USA, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The RNA-based Therapeutics and Vaccines Market was valued at USD 1,285.10 million in 2024 and is projected to reach approximately USD 2,320.54 ...

It may contain inaccuracies due to the limitations of machine translation. Moderna's COVID-19 vaccine. It showed 94.1% efficacy in Phase 3 clinical trials. The company applied for Emergency Use ...

Key market opportunities in the RNA extraction and purification sector include the growing demand for RNA-based therapies and diagnostics, the development of user-friendly and automated kits, and the ...

ETHealthworld.com brings latest mrna vaccine news, views and updates from all top sources for the Indian Health industry.

New partnership targets foot-and-mouth disease with scalable, next-generation technology A new global collaboration is aiming to bring next-generation RNA vaccine technology into livestock health, as ...